BRG Borregaard

Borregaard ASA: Annual general meeting – new date

Borregaard ASA: Annual general meeting – new date

In light of the situation related to covid-19 and current restrictions on travels and meetings, the Board of Borregaard has today decided to postpone the Annual General Meeting. The new date is Monday 15 June 2020. The financial calendar will be updated accordingly.

As a consequence of the postponed Annual General Meeting the proposed ordinary dividend of NOK 2.30 per share will be paid out at a later date than previously announced (see stock exchange notice of 5 February 2020). A separate notice containing payment date and other key information related to the cash dividend will be sent out shortly.

Sarpsborg, 18 March 2020

Contact:

Jørn Syvertsen, Director Investor Relations,

This information is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

EN
18/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000. Start date: 12 December, 2025Maturity: 12 February, 2026Coupon: 4,43 %Organised by: DNB Carnegie Sarpsborg, 10 December 2025 Contact:CFO, Per Bjarne Lyngstad, +47 952 44 515 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioS...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch